ArticleFrontiers in medicine2026
Deep learning reconstruction improves detection of focal liver lesions in hepatobiliary phase compared to conventional EOB-MRI.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In recent years, the application of Deep Learning Reconstruction (DL Recon) technology in MRI has significantly improved the detection rate of small focal liver lesions (FLLs). This study aims to compare the detection performance of DL Recon EOB-MRI with traditional Gd-EOB-DTPA-enhanced liver MRI during the hepatobiliary phase (HBP) for FLL detection. Methods: This prospective, single-center study included 53 patients who underwent EOB-MRI during the hepatobiliary phase (HBP). For each patient, four types of images were acquired: 3 mm thickness non-DL reconstruction (Standard Non-DL), 3 mm thickness DL reconstruction (Standard DL), 1 mm thickness non-DL reconstruction (HR Non-DL), and 1 mm thickness DL reconstruction (HR-DL). Lesions were categorized based on signal intensity into high-signal and low-signal types, and classified into five size groups: >30 mm, 20-30 mm, 10-20mm, 5-10mm, and <5 mm. Three abdominal radiologists independently assessed the number of FLLs on HBP images. Pairwise comparisons between the four types of images were made using the Wilcoxon signed-rank test and Generalized Estimating Equations to assess differences. Results: The intraclass correlation coefficient (ICC) between all groups was >0.90, indicating excellent consistency ( Conclusion: DL-Recon combined with MR techniques demonstrates significant clinical value in enhancing the detection of small low-signal lesions in EOB-MRI hepatobiliary phase, significantly improving the detection rate of FLLs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.